(Q33343211)

26 July 2017

Vinorelbine in previously treated advanced childhood sarcomas: evidence of activity in rhabdomyosarcoma (English)

1 reference

26 July 2017

1 reference

Monica Terenziani

4

0 references

Roberto Luksch

Roberto Luksch

6

0 references

Filippo Spreafico

Filippo Spreafico

3

0 references

Michela Casanova

Michela Casanova

1

0 references

Maura Massimino

Maura Massimino

5

0 references

Andrea Ferrari

Andrea Ferrari

2

0 references

author name string

Graziella Cefalo

7

1 reference

26 July 2017

Daniela Polastri

8

1 reference

26 July 2017

Ilaria Marcon

9

1 reference

26 July 2017

Franca Fossati Bellani

10

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

26 July 2017

1 reference

26 July 2017

94

1 reference

26 July 2017

3263-3268

1 reference

26 July 2017

12

1 reference

Phase I pharmacologic study of a new Vinca alkaloid: navelbine

26 July 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10600

Vinorelbine (Navelbine): a third-generation vinca alkaloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10600

Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10600

Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10600

Topotecan in pediatric patients with recurrent and progressive solid tumors: a Pediatric Oncology Group phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10600

Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: an intergroup rhabdomyosarcoma study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10600

Current position of vinorelbine in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10600

7 January 2021

Vinorelbine is an effective and safe drug for AIDS-related Kaposi's sarcoma: results of a phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10600

7 January 2021

A phase II trial of ifosfamide in previously untreated children and adolescents with unresectable rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10600

7 January 2021

Phase II testing of melphalan in children with newly diagnosed rhabdomyosarcoma: a model for anticancer drug development

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10600

7 January 2021

Phase II window studies: 10 years of experience and counting

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10600

7 January 2021

Identifiers

DOI

10.1002/CNCR.10600

1 reference

26 July 2017

1 reference